No­var­tis gets a boost in block­buster mul­ti­ple scle­ro­sis race with Roche

1 hour ago
R&D

Coro­n­avirus out­break threat­ens short­age of 150 drugs — re­port

1 hour ago
China
Pharma

Drug ap­provals: FDA pub­lish­es dataset of CDER ap­provals since 1985

2 hours ago
Regulatory

An­i­mal health vet Juer­gen Horn makes new an­ti­body play for pets, rak­ing $15M in Se­ries A haul

2 hours ago
Startups
Venture

As coro­n­avirus out­break reach­es 'tip­ping point,' GSK lends ad­ju­vant tech to Chi­nese part­ner armed with pre­clin­i­cal vac­cine

3 hours ago
China
Coronavirus

The fourth CGRP mi­graine drug is here. Time for Lund­beck to prove it's worth $2B

Yesterday
Pharma
Regulatory

Es­pe­ri­on's goldilocks cho­les­terol fight­er wins FDA ap­proval — will its 'tra­di­tion­al' pric­ing ap­proach spur adop­tion?

2 days ago
Pharma
Regulatory

UP­DAT­ED: A space odyssey for new an­tibi­otics: MIT's ma­chine learn­ing ap­proach

2 days ago
AI
R&D

Gen­fit de­lays high-stakes PhI­II NASH read­out; Bris­tol-My­ers grabs first Op­di­vo OK in esophageal can­cer

2 days ago
Protocols

Gilead los­es two more patent chal­lenges on HIV pill, set­ting up court­room fight in Delaware

2 days ago
R&D

Bank­rupt an­tibi­otics mak­er Ar­a­digm turns to old part­ner/in­vestor for fi­nal $3M fire sale

2 days ago
Deals

DB­V's peanut pre­ven­tion patch ap­proach­es key stage of ap­proval process

2 days ago
R&D

An­to­nio Gual­ber­to starts post-Ku­ra ca­reer at Ei­sai sub­sidiary H3; eF­FEC­TOR co-founder Siegfried Re­ich jumps to Turn­ing Point

2 days ago
Peer Review

Say good­bye to Toca­gen, strug­gling brain can­cer biotech to re­verse merge with Forte Bio­sciences

3 days ago
Deals

Speedy re­view and no ad­comm for Bio­Mar­in's pi­o­neer­ing he­mo­phil­ia gene ther­a­py

3 days ago
Cell/Gene Tx
Regulatory

Gene ther­a­py pi­o­neer Kathy High has left Spark af­ter com­plet­ing $4.3B union with Roche

3 days ago
Cell/Gene Tx
People

Phar­ma­co­ge­net­ics: FDA re­leas­es ta­ble of gene-drug in­ter­ac­tions

3 days ago
Pharma
Regulatory

Heron's Ground­hog Day; Vi­for forms JV with Fre­se­nius Kabi in Chi­na

3 days ago
Protocols

Fresh off $100M round, GV-backed re­al-world da­ta start­up woos Duke re­searcher as CMO

3 days ago
People
Startups

Mer­ck los­es its chief dig­i­tal of­fi­cer, spot­light­ing tal­ent hunt for the hottest ti­tle in Big Phar­ma

4 days ago
People
R&D

Don't let Ab­b­Vie fool FTC with an easy di­vesti­ture, plead crit­ics in lat­est at­tack on $63B Al­ler­gan buy­out

4 days ago
Deals
Pharma

Auste­do, Teva's bright spot as it ex­e­cutes turn­around, fails two Touret­te's tri­als

4 days ago
Pharma

Armed with a batch of pos­i­tive bio­mark­er da­ta, a rare dis­ease play­er reaps $88M for the next big push in the clin­ic

4 days ago
R&D

FDA con­sol­i­dates non­clin­i­cal im­muno­tox­i­c­i­ty eval­u­a­tion guid­ance

4 days ago
Regulatory
1234 Next page Last page